Capital Research & Management Co recently announced the acquisition of new stake in AES Corp. (NYSE:AES). The institutional investor has increased its shareholding in the Utilities company by 5.85% to 67.13 million shares with purchase of 3.71 million shares. This fresh investment now brings its stake to 10.03% valued currently at $1.29 billion. In addition, BlackRock Fund Advisors raised its holdings by 1.43 million to 36.16 million shares. And Fidelity Management & Research Co has lifted its position by 34.46% or 6.69 million shares – to 26.12 million shares.
Currently, there are 668.74M common shares owned by the public and among those 665.40M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 50 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 26 of these insider trades were purchases, accounting for 631,142 shares. Insider sales of the common stock occurred on 24 occasions, with total insider shares sold totaling 192,385 shares.
The top 3 mutual fund holders in AES Corp. are American Funds Fundamental Invest, American Funds Income Fund of Ame, and Vanguard Total Stock Market ETF. American Funds Fundamental Invest owns 37.4 million shares of the company’s stock, all valued at over $719.87 million. The company bought an additional 15.63 million shares recently to bring their total holdings to about 5.59% of the shares outstanding. American Funds Income Fund of Ame bought 1.65 million shares to see its total holdings expand to 23.32 million shares valued at over $448.89 million and representing 3.48% of the shares outstanding. Vanguard Total Stock Market ETF bought 19861.0 shares to bring its total holdings to over 21.03 million shares at a value of $404.82 million. Vanguard Total Stock Market ETF now owns shares totaling to 3.14% of the shares outstanding.
The company’s stock has a 5-day price change of -9.00% and 21.24% over the past three months. AES shares are trading -12.83% year to date (YTD), with the 12-month market performance down to -37.01% lower. It has a 12-month low price of $11.43 and touched a high of $27.71 over the same period. AES has an average intraday trading volume of 6.63 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -9.87%, -6.47%, and -11.80% respectively.
Institutional ownership of AES Corp. (NYSE: AES) shares accounts for 94.55% of the company’s 668.74M shares outstanding. Mutual fund holders own 31.04%, while other institutional holders and individual stakeholders account for 64.06% and 23.93% respectively.
It has a market capitalization of $11.24B and a beta (3y monthly) value of 1.09. The earnings-per-share (ttm) stands at -$0.87. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.34% over the week and 2.84% over the month.
Analysts forecast that AES Corp. (AES) will achieve an EPS of $0.63 for the current quarter, $0.35 for the next quarter and $1.9 for 2024. The lowest estimate earnings-per-share for the quarter is $0.32 while analysts give the company a high EPS estimate of $0.73. Comparatively, EPS for the current quarter was $0.49 a year ago. Earnings per share for the fiscal year are expected to increase by 3.12%, and 10.65% over the next financial year. EPS should grow at an annualized rate of 7.50% over the next five years, compared to 0.38% over the past 5-year period.
Looking at the support for the AES, a number of firms have released research notes about the stock. UBS stated their Neutral rating for the stock in a research note on October 06, 2023, with the firm’s price target at $22-$13.
